Table 1.

Lipid profile of C57 atherosclerotic mice, treated with prodigiosin and undecylprodigiosin for 28 days.

Group	TC (mg/dL)	HDL-C (mg/dL)	LDL-C (mg/dL)	TG (mg/dL)
Control	1585 ± 400	35.2 ± 6.1	1376 ± 100.5	435.0 ± 114.7
P50	1480 ± 193	28.7 ± 6.7	1367 ± 208.4	423.3 ± 90.0
P500	1735 ± 238	22.8 ± 8.6	1602 ± 193.7	402.0 ± 64.2
U50	1653 ± 326	35.3 ± 7.4	1535 ± 371.7	411.7 ± 140.3
U500	1616 ± 391	28.3 ± 11.9	1435 ± 459.0	435.7 ± 68.0

TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TG, triglycerides; P50, 50 µg/Kg/day PG; P500, 500 µg/Kg/day PG; U50, 50 µg/Kg/day UPG; U500, 500 µg/Kg/day UPG. The analyte content was measured in all individuals of each group.